Direct antithrombins: New perspectives in cardiovascular medicine

Current Medicinal Chemistry: Cardiovascular and Hematological Agents

Volumn 2, Issue 3, 2004, Pages 267-275

  Lettino, M ^a,b   Toschi, V ^a,b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Acute coronary syndromes; Anticoagulants; Hirudin; Thrombin; Thrombosis; Venous thromboembolism

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; ANTICOAGULANT AGENT; ANTITHROMBIN; ARGATROBAN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; EFEGATRAN; ENOXAPARIN; FIBRIN; FIBRINOGEN; FIBRONECTIN; FONDAPARINUX; GLYCOPROTEIN; HEPARIN; HIRUDIN; HIRULOG; INOGATRAN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; MEMBRANE RECEPTOR; PLACEBO; PROPIONIC ACID DERIVATIVE; STREPTOKINASE; THROMBIN; THROMBOPLASTIN; TICK ANTICOAGULANT PEPTIDE; TISSUE FACTOR PATHWAY INHIBITOR; UNINDEXED DRUG; VITRONECTIN; XIMELAGATRAN;

ARTERY EMBOLISM; ARTERY THROMBOSIS; ARTHROPLASTY; BINDING AFFINITY; BINDING SITE; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG URINE LEVEL; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; RESTENOSIS; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTITHROMBINS; CARDIOVASCULAR AGENTS; CLINICAL TRIALS; HEPARIN; HIRUDIN THERAPY; HUMANS; THROMBIN; THROMBOSIS;

EID: 3042699985     PISSN: 15680169     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568016043356291     Document Type: Review

References (66)

1. Sword, N.A.; Mann, F.G. Arterioscler. Thromb., 1993, 13, 1602.
2. Fenton, J.W. II; Ofosu, F.A.; Brezniak, D.V.; Hassouna, H.I. Hematol./Oncol. Clin. N. Am., 1993, 7, 1107.
3. Mann, K.G. In Hemostasis and thrombosis: Basic principles and clinical practice; Robert W. Colman, Jack Hirsh, Victor J. Marder, Edwin W. Salzman, Eds.; J.B. Lippincott Company: Philadelpia, 1994, pp. 184-199.
4. Stubbs, M.Y.; Bode, W. Thromb. Res., 1993, 69, 1.
5. Toschi, V.; Gallo, R.; Lettino, M.; Fallon, J.T.; Gertz, S.D.; Fernandez-Ortiz, A.; Chesebro, J.H.; Badimon, L.; Nernerson, Y.; Fuster, V.; Badimon, J.J. Circulation, 1997, 95, 594.
6. Fuster, V. Circulation, 1994, 90, 2126.
7. Harker, L.A.; Hanson, S.R.; Runge, M.S. Am. J. Cardiol., 1995, 75, 12B.
8. Weitz, J.I.; Hudoba, M.; Massel, D.; Maraganore, J.; Hirsh, J. J. Clin. Invest., 1990, 86, 385.
9. Kumar, R.; Béguin, S.; Hemker, H.C. Thromb. Haemost., 1994, 72, 713.
10. Meyer, B.J.; Badimon, J.J.; Mailhac, A.; Fernàndez-Ortiz, A.; Chesebro, J.H.; Fuster, V.; Badimon, L. Circulation, 1994, 90, 2432.
11. Kumar, R.; Béguin, S.; Hemker, H.C. Thromb. Haemost., 1995, 74, 962.
12. Liaw, P.C.; Becker, D.L.; Stafford, A.R.; Fredenburgh, J.C.; Weitz, J.I. J. Biol. Chem., 2001, 276, 20959.
13. Gallo, R.; Padurean, A.; Toschi, V., Bichler, J.; Fallon, J.T.; Chesebro, J.; Fuster, V.; Badimon, J.J. Circulation, 1998, 97, 581.
14. Hirsh, J.; Raschke, R.; Warkentin, T.E.; Dalen, J.E.; Deykin, D.; Poller, L. Chest, 1995, 8(suppl.), 259.
15. Eisenberg, P.R.; Siegel, J.E.; Abendschein, D.R.; Mileth, J.P. J. Clin. Invest., 1993, 91, 1877.
16. Hogg, P.J.; Bock, P.E. Thromb. Haemost., 1997, 77, 424.
17. Broze, G.J. Jr. Thromb. Haemost., 1995, 74, 90.
18. Badimon, J.J.; Lettino, M.; Toschi, V.; Fuster, V.; Berrozpe, M.; Chesebro, J.H.; Badimon, L. Circulation, 1999, 99, 1780.
19. Oltrona, L.; Speidel, C.M.; Recchia, D.; Wiekline, S.A.; Eisenberg, P.R.; Abendschein, D.R. Circulation, 1997, 96, 646.
20. Haskel, E.J.; Torr, S.R.; Day, K.C.; Palmier, M.O.; Wun, T.C.; Sobel, B.E.; Abendschein, D.R. Circulation, 1991, 84, 821.
21. Abraham, E. Crit. Care Med., 2000, 28, 831.
22. Pawashe, A.B.; Golino, P.; Ambrosio, G.; Migliaccio, F.; Ragni, M.; Pascucci, I.; Chiariello, M.; Bach, R.; Garen, A.; Konigsberg, W.K.; Ezekowitz, M.D. Circ. Res., 1994, 74, 56.
23. Ragni, M.; Cirillo, P.; Pascucci, I.; Scognamiglio, A.; D'Andrea, D.; Eramo, N.; Ezekowitz, M.D.; Pawashe, A.B.; Chiariello, M.; Golino, P. Circulation, 1996, 93, 1913.
24. Rao, L.V.M.; Ezban, M. Blood Coagul. Fibrinolysis, 2000, 1, S135.
25. Samama, M.M. Thromb. Res., 2002, 106, V267.
26. Lassen, M.R.; Bauer, K.A., Eriksson, B.I.; Turpie, A.G.G., for the European Pentasaccaride Hip Elective Surgery Study (EPHESUS) Steering Committee. Lancet, 2002, 359, 1715.
27. Turpie, A.G.G.; Bauer, K.; Eriksson, B.I.; Lassen, M.R.; for the PENTATHLON 2000 Study Steering Committe. Lancet, 2002, 359, 1721.
28. Lee, A.; Agnelli, G.; Buller, H.; Ginsberg, J.; Heit, J.; Rote, W.; Vlasuk, G.; Costantini, L.; Julian, J.; Comp, P.; van der Meer. J.; Piovella, F.; Raskob, G.; Gent, M. Circulation, 2000, 104, 74.
29. Toschi, V.; Lettino, M.; Gallo, R.; Badimon, J.J.; Chesebro, J.H. Coron. Artery Dis., 1996, 7, 420.
30. Talbot, M. Semin. Thromb. Hemost., 1989, 15, 293.
31. Stone, S.R.; Hofsteenge, J. Biochemistry, 1986, 25, 4622.
32. Maraganore, J.M.; Bourdon, P.; Jablonski, J.; Ramachandran, K.L.; Fenton, J.W. J. Clin. Invest., 1990, 29, 7095.
33. Skrzypczak-Jankun, E., Carperos, V.E.; Ravichandran, K.G., Tulinsky, A.; Westbrook, M., Maraganore, J.M. J. Mol. Biol., 1991, 221, 1379.
34. Witting, J.I.; Bourdon, P.; Brezniak, D.V.; Maraganore, J.M.; Fenton, J.W. II. Biochem. J., 1992, 283, 737.
35. Fox, I.; Dawson, A.; Loynds, P.; Eisner, J.; Findlen, K.; Levin, E.; Hanson, D.; Mant, T.; Wagner, J.; Maraganore, J. Thromb. Haemost., 1993, 69, 157.
36. Hursting, M.J.; Alford, K.L.; Becker, J.C.; Brooks, R.L.; Joffrion, J.L.; Knappenberger, G.D.; Knappenberger, G.D.; Kogan, P.W.; Kogan, T.P.; McKinney, A.A.; Schwarz, R.P. Jr. Semin. Thromb. Haemost. 1997, 23, 503.
37. Banner, D.W.; Hadvary, P. Adv. Exp. Med. Biol., 1993, 340, 27.
38. Swan, S.K.; Husting, M.J. Pharmacotherapy, 2000, 20, 318.
39. Klootwijk, P., Lenderink, T.; Meij, S.; Boersma, H.; Melkert, R.; Umans, V.A.; Stibbe, J.; Muller, E.J.; Poortermans, K.J.; Deckers, J.W., Simoons, M.L. Eur. Heart. J., 1999, 20, 1101.
40. Fung, A.Y.; Lorch, G.; Cambier, P.A., Hansen, D.; Titus, B.G., Martins, J.S.; Lee, J.J.; Every, N.R.; Hallstrom, A.P.; Stock-Novack, D.; Scherer, J.; Weaver, W.D. Am. Heart. J., 1999, 138, 696.
41. Gustafsson, D.; Nystrom, J-E.; Carlsson, S.; Bredberg, U.; Eriksson, U.; Gyzander, E.; Elg, M.; Antonsson, T.; Hoffmann, K.; Ungell, A.; Sorensen, H.; Nagard, S.; Abrahamsson, A.; Bylund, R. Thromb. Res., 2001, 101, 171.
42. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. Circulation, 1997, 96, 769.
43. Organization to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators. Lancet, 1999, 335, 429.
44. Antman, E.M. for the TIMI 9A Investigators. Circulation, 1994, 90, 1624.
45. Neuhaus, K.L.; von Essen, R.; Tebbe, U.; Jessel, A.; Heinrichs, H.; Maurer, W.; Doting, W.; Harmjanz, D.; Kotter, V.; Kalhammer, E.; Simon, H.; Horacek, T.; Circulation, 1994, 90, 1638.
46. The GUSTO IIa Investigators. Circulation, 1994, 90, 1631.
47. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N. Engl. J. Med., 1996, 335, 775.
48. Antman, E.M. Circulation, 1996, 94, 911.
49. Serruys, P.W.; Herrman, J.P.; Simon, R.; Rutsch, W.; Bode, C.; Laarman, G.J.; van Dijk, R.; van den Bos, A.A.; Umans, V.A.; Fox, K.A.; Close, P.; Deckers, J.W. for The Helvetica Investigators. N. Engl. J. Med., 1995, 333, 757.
50. Eriksson, B.I.; Ekman, S.; Lindbratt, S.; Baur, M.; Bach, D.; Torholm, C.; Kalebo, P.; Close. P. J. Bone Joint. Surg. Am., 1997, 79, 326.
51. Eriksson, B.I.; Wille-Jorgensen. P.; Kalebo, P.; Mouret, P.; Rosencher, N.; Bosch, P.; Baur, M.; Ekman, S.; Bach, D.; Lindbratt, S.; Close, P. N. Engl. J. Med., 1997, 337, 1329.
52. Schiele, F.; Lindgaerde, F.; Friksson, H.; Bassand, J.P.; Wallmark, A.; Hanson, P.O., Grollier, G.; Sjo, M.; Moia, M.; Camez, A.; Smyth, V.; Walker, M. Thromb. Haemost., 1997, 77, 834.
53. Bittl, J.A.; Chaitman, B.R.; Feit, F.; Kimball, W.; Topol, E.J. Am. Heart J., 2001, 142, 952.
54. The Hirulog and Early Reperfsion or Occlusion (HERO)-2 Trial Investigators. Lancet, 2001, 358, 1855.
55. Kong, D.F.; Topol, E.J.; Bittl, J.A.; White, H.D.; Theroux, P.; Hasselblad, V.; Califf, R.M. Circulation, 1999, 100, 2049.
56. Carswell, C.I.; Plosker, G.L. Drugs, 2002, 62, 841.
57. Direct Thrombin Inhibitor Trialists' Collaborative Group. Lancet, 2002, 359, 294.
58. Vermeer, F.; Vahanian, A.; Fels, P.W.; Besse, P.; Muller, E.; Van de Werf, F.; Fitzgerald, D.; Darius, H.; Puel, J.; Garrigou, D.; Simoons, M.L. ARGAMI Study Group. J. Thromb. Thrombolysis, 2000, 10, 233.
59. Eriksson, B.I.; Bergqvist, D.; Kalebo, P., Dahl, O.E.; Lindbratt, S.; Bylock, A.; Frison, L.; Eriksson, U.G.; Welin, L.; Gustafsson, D.; Melagatran for Thrombin inhibition in Orthopaedic surgery. Lancet, 2002, 360, 1441.
60. Eriksson, B.I.; Agnelli, G.; Cohen, A.T.; Dahl, O.E.; Mouret, P.; Rosencher, N.; Eskilson, C.; Nylander, I.; Frison, L.; Ogren, M. Thromb. Haemost., 2003, 89, 288.
61. Heit, J.A.; Colwell, C.W.; Francis, C.W.; Ginsberg, J.S.; Berkowitz, S.D.; Whipple, J.; Peters, G.; AstraZeneca Arthroplasty Study Group. Arch. Intern. Med., 2001, 161, 2215.
62. Francis, C.W.; Davidson, B.L.; Berkowitz, S.D.; Lotke, P.A.; Ginsberg, J.S.; Lieberman, T.R.; Webster, A.K.; Whipple, J.P.; Peters, G.R.; Colwell, C.W. Jr. Ann. Intern. Med., 2002, 137, 648.
63. Eriksson, H.; Wahlander, K.; Gustafsson, D.; Welin, Lt. L.; Frison, L.; Schulman, S.: For the thrive investigators. J. Thromb. Haemost., 2003, 1, 41.
64. Petersen, P.; Grind, M.; Adler, J.: SPORTIF [I Investigators. J. Am. Coll. Cardiol, 2003, 41, 1445.
65. Boersma, E.; Harrington, R.A.; Moliterno, D.J.; White, H.; Simoons, M.L. Lancet, 2002, 360, 342.
66. Lincoff, A.M.; Bittl, T.A.; Harrington, R.A., Feit, F.; Kleiman, N.S.; Jackman, J.D.; Sarembock, I.J.; Cohen, D.J; Spriggs, D.; Ebrahimi, R.; Keren, G.; Carr, J.; Cohen, E.A.; Betriu, A.; Desmet, W.; Kereiakes, D.J., Rutsch, W.; Wilcox, R.G.; de Feyter, P.J.; Vahanian, A.; Topol, E..J.: REPLACE-2 Investigators. JAMA, 2003, 289, 853.